Alopecia areata in London: a clinician's guide to patches, JAK inhibitors and the NHS pathway

The first patch usually appears overnight. A smooth, coin-sized circle of bare scalp — often discovered by a hairdresser, partner or barber before the person themselves. It is one of the most disorienting moments in dermatology, and one of the most commonly misdiagnosed.

Alopecia areata affects roughly 2% of the UK population at some point. In London, dermatology clinics see a clear bimodal age distribution: teenagers and adults in their thirties. This guide, reviewed with consultant dermatologists at two London teaching hospitals, walks through what is happening, what works, and how to navigate the NHS and private routes in 2026.

What alopecia areata actually is

Alopecia areata is an organ-specific autoimmune condition. The immune system mistakes anagen-phase hair follicles for foreign tissue and attacks the follicle bulb, halting hair production. Crucially, the follicle itself is not destroyed — which is why regrowth is possible, sometimes spontaneously.

It is not caused by stress, shampoo, hard water, diet, or anything you did. Stress can trigger flares in someone genetically predisposed, but it does not cause the underlying condition. The genetic association is strong: roughly 20% of patients have a first-degree relative with an autoimmune disease.

The four presentations London clinicians see

Alopecia areata is a spectrum, and the presentation determines both prognosis and treatment.

• Patchy alopecia areata — one or more discrete patches, usually on the scalp. ~80% of cases. Highest spontaneous regrowth rate.
• Alopecia totalis — complete loss of all scalp hair. Lower spontaneous remission.
• Alopecia universalis — loss of all body hair, including eyebrows, lashes and body hair. Historically the hardest to treat; JAK inhibitors have changed this.
• Ophiasis pattern — a band-like loss along the occipital and temporal hairline. Often more treatment-resistant.

What to do when you find a patch

Photograph it under consistent lighting with a ruler or coin for scale. Do this weekly. This single habit is the most useful diagnostic tool a London dermatologist will ask for at your first appointment.

Then book a GP appointment to request a dermatology referral. NHS waits in London vary from 8 weeks (Guy's, King's) to 9 months in outer boroughs. If the patch is enlarging week-on-week, or you have more than one, go private — £180–£300 buys you a same-week consultation, trichoscopy and a treatment plan.

First-line treatments in 2026

For limited patchy disease, intralesional triamcinolone (steroid injections directly into the patch, every 4–6 weeks) remains the most effective and evidence-backed option. Regrowth typically begins at 6–8 weeks. Side effect: temporary skin atrophy if overdosed — this is why London clinics use 2.5–5 mg/mL, not higher.

Topical minoxidil 5% is often added — not because it suppresses the autoimmunity, but because it shortens the time follicles spend in the resting phase, accelerating cosmetic recovery.

Topical immunotherapy (DPCP, SADBE) is offered at a handful of London centres — King's, Guy's, the Royal London — for extensive disease that has not responded to steroids. It involves deliberately inducing a mild contact dermatitis to redirect the immune response. Effective in 40–60% of carefully selected cases.

The JAK inhibitor era

In June 2024, NICE approved ritlecitinib (Litfulo) for severe alopecia areata in patients aged 12 and over, and baricitinib (Olumiant) for severe disease in adults. This is the first targeted systemic therapy with regulatory approval for the condition — a genuine inflection point.

Efficacy: in pivotal trials, roughly 40% of patients with severe disease achieved 80%+ scalp coverage at 36 weeks. Onset is slow — meaningful regrowth at 3–6 months, plateau around 12 months. Treatment is typically ongoing; relapse on stopping is common.

Access in London: NHS access is via specialist dermatology referral and requires SALT score ≥50 (i.e. 50%+ scalp loss). Privately, several Harley Street and Marylebone clinics now prescribe; expect £400–£700/month plus monitoring bloods.

What does not work (despite the marketing)

Save your money on: rosemary oil for active alopecia areata, PRP for the autoimmune subtype (works for androgenetic, not autoimmune), LED therapy as monotherapy, biotin supplements, and most 'alopecia restoration' programmes that promise 'natural reversal'. None of these address the underlying T-cell-mediated attack.

Mesotherapy and 'scalp boosters' with hyaluronic acid have no evidence in alopecia areata and may delay appropriate treatment — months matter, especially if disease is progressing.

The psychological piece

Sudden visible hair loss is a grief event. Alopecia UK (the national charity) runs in-person support groups in London — Soho monthly, plus a strong online community. Many London dermatology clinics now refer routinely to clinical psychology alongside treatment; ask for this at your first consultation if you want it.

Cosmetic camouflage — concealer powders, scalp microblading, custom topper systems — is legitimate medicine, not vanity. A handful of London specialists (notably in Marylebone and Notting Hill) do excellent work that holds up in daylight and on video.

London-specific routes

NHS: GP → dermatology referral. Best London centres for complex alopecia areata: St John's Institute of Dermatology (Guy's), the Royal London, King's College Hospital. Wait times 2–9 months depending on borough.

Private: £180–£300 for an initial consultation with trichoscopy. JAK inhibitor monitoring £150–£250/month on top of the prescription. Always confirm the clinician is a GMC-registered consultant dermatologist before paying.